Health Status of Patients After Surgically Implanted Biological and TAVI: a Population-based Retrospective Analysis

Medical University of Vienna18,882 enrolled

Overview

The overall project aim is to study outcomes following aortic valve replacement with surgically implanted bioprostheses or TAVI by retrieving data from the main social security carriers in Austria for the years 2010-2020.

Study Type

OBSERVATIONAL

Enrollment

18,882

Conditions

Aortic Valve Disease

Interventions

Aortic Valve ReplacementDEVICE

Aortic Valve Replacement (surgically or TAVI)

Eligibility

Sex: ALLMin age: 65 YearsMax age: 99 Years

Medical Language ↔ Plain English

Inclusion Criteria: * isolated aortic valve replacement in Austria (surgically implanted bioprostheses or TAVI) Exclusion Criteria: * below 65 years of age * coronary revascularization within 4 months before the index procedure * concomitant heart surgery

Outcomes

Primary Outcomes

all-cause mortality

all cause mortality after aortic valve replacement

Time frame: 10 years

Secondary Outcomes

reoperation

incidence of reoperation after aortic valve replacement

Time frame: 10 years

myocardial infaction

incidence of myocardial infaction after aortic valve replacement

Time frame: 10 years

heart failure

incidence of heart failure after aortic valve replacement

Time frame: 10 years

stroke

incidence of stroke after aortic valve replacement

Time frame: 10 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.